Alberta
How natural gas supports one of Canada’s largest manufacturing sectors

Worker inspecting parts from plastic injection moulding machine in plastics factory. Getty Images photo
From the Canadian Energy Centre
‘When you think about the demand for more sustainable outcomes: clean air, clean water, clean energy, safe, nutritious, abundant food and electric vehicles, that’s more and more and more chemistry’
Canada’s chemical industry sold a record $72.7 billion of product last year amid recovery from COVID-19 and strong consumer demand, according to the Chemistry Industry Association of Canada (CIAC).
Natural gas is a key input to the chemistry sector, the broad term that refers to manufacturing a myriad of products used in everyday items from plastics to agriculture and pharmaceuticals.
“Chemistry products go into 95 per cent of finished goods. It’s an important sector,” says CIAC president Bob Masterson.
“It’s a sector that can grow as long as we fancy improving our lives and building a better world for tomorrow.”
Chemicals in Canada
Canada’s chemistry industry is the country’s fourth largest manufacturing sector by value of sales after food ($147 billion), transportation equipment ($119 billion), and petroleum/coal products ($118 billion).
It is primarily centered in Ontario, Alberta and Quebec.
The CIAC publishes an annual report on the sector’s activity using Statistics Canada data, separated into two categories: chemicals overall, and industrial chemicals.
Chemicals overall includes manufacturing of soaps, cleaning compounds, paints, coatings and adhesives, pesticides and fertilizers, pharmaceuticals, rubbers and synthetic fibres, and basic chemicals.
Industrial chemicals refers to the manufacturing of intermediate products used as inputs by industries including plastic and rubber products, forest products, transportation equipment, clothing, perfume and cosmetics, construction and pharmaceuticals.
Global Growth
According to Vantage Market Research, the global chemical market was valued at US$584 billion in 2022. It’s expected to grow by more than 55 per cent in the coming years to reach US$917 billion by 2030.
This isn’t just driven population growth, Masterson says.
“When you think about the demand for more sustainable outcomes: clean air, clean water, clean energy, safe, nutritious, abundant food and electric vehicles, that’s more and more and more chemistry,” he says.
“Some of the predictions are that the volumes of chemistry will double in the next 20 years. Canada and Alberta in particular are exceptionally well positioned to help meet future market demand for these products. The demand is not going away. There’s no question about that.”
Jobs
In 2022, Canada’s chemicals sector directly employed 90,800 people, or approximately the population size of Sudbury, Ontario. The industry paid about $7 billion in salary and wages.
That’s the direct impact of employment in the chemistry sector, but the CIAC estimates the full benefit to Canadians to be much higher as a result of indirect economic activity it supports.
CIAC estimates that every job in Canada’s chemistry sector creates another five indirect jobs in other parts of the economy. This means the sector supported 454,000 jobs across Canada in 2022.
Industrial chemicals alone directly employed 17,100 people and indirectly supported 85,600 jobs in the broader Canadian economy last year, the CIAC says.
Rising Trade
At a value of $72.7 billion, Canada’s overall chemical industry sales were their highest ever in 2022 – a 30 per cent increase compared to 2019, prior to the COVID-19 pandemic.
Industrial chemicals sales reached a record $34.2 billion, a 32 per cent increase compared to 2019.
Exports also increased last year, rising to a value of $52.8 billion compared to $45.9 billion in 2021. Of that, the sector exported $24.8 billion of industrial chemicals, up from $22.5 billion the previous year.
The United States is Canada’s main customer for chemical exports, representing 76 per cent of exports or $40.1 billion in 2022. The next largest export markets are China ($1.86 billion), the Netherlands ($1.7 billion), and the United Kingdom ($1.1 billion).
The Canada Advantage
Canada has distinct advantages as a chemical manufacturer and exporter including growing access to global markets, CIAC says.
In Alberta, the main advantage is access to low-cost natural gas resources – specifically valuable natural gas liquids like ethane, propane and butane.
“The rich abundance of natural gas liquids that come out of the ground when we drill for natural gas let Alberta be a low-cost chemistry producer despite being pretty much the only large chemistry industry worldwide that’s not on tidewater,” Masterson says.
Responsible Care
Since 1985, Canada’s chemistry industry has operated under an initiative called Responsible Care that encourages companies to innovate for safer and greener products.
CIAC reports that Responsible Care is now practiced in 73 countries and by 96 of the 100 largest chemical producers in the world.
Since 2005, CIAC members have reduced CO2 equivalent emissions by 13 per cent; reduced sulphur dioxide emissions by 94 per cent, and virtually eliminated large scale safety incidents. Since 2012, CIAC members have also reduced net water consumption by 13 per cent.
“We’re not standing in place,” Masterson says.
Alberta
Medical regulator stops short of revoking license of Alberta doctor skeptic of COVID vaccine

From LifeSiteNews
The Democracy Fund has announced that COVID-skeptic Dr. Roger Hodkinson will retain his medical license after a successful appeal against allegations of ‘unprofessional conduct’ by the College of Physicians and Surgeons of Alberta.
A doctor who called for officials to be jailed for being complicit in the “big kill” caused by COVID measures will get to keep his medical license thanks to a ruling by a Canadian medical regulator.
The Democracy Fund (TDF) announced in an April 4 press release that one of its clients, Dr. Roger Hodkinson, will retain his medical license after filing an appeal with the College of Physicians and Surgeons of Alberta (CPSA) over allegations of “unprofessional conduct regarding 17 public statements made in November 2020 and April 2021.”
Hodkinson had routinely argued against the dictates of public health and elected officials and “presented an alternative perspective on COVID-19, including the efficacy of masking and vaccines,” TDF noted.
In 2021, Hodkinson and Dr. Dennis Modry publicly blasted the then-provincial government of Alberta under Premier Jason Kenney for “intimidating” people “into compliance” with COVID-19 lockdowns.
In 2022, Hodkinson said that leaders in Canada and throughout the world have perpetrated the “biggest kill ever in medicine’s history” by coercing people into taking the experimental COVID injections and subjecting them to lengthy lockdowns.
These statements, among others, led the CPSA to claim that Hodkinson had promoted inaccurate or misleading information. “However, following negotiations with lawyers for The Democracy Fund, the CPSA limited its claims to arguing that Dr. Hodkinson’s comments violated the ethical code and extended beyond the scope of a general pathologist.”
Thus, Hodkinson did not “concede that any of his statements were false,” but “acknowledged that his criticisms of other physicians technically breached the Code of Ethics and Professionalism,” the group explained. “He also admitted that he should have clarified that his views were outside the scope of a general pathologist.”
Instead of having his license revoked, TDF stated that Dr. Hodkinson received a “caution” and will have to “complete an online course on influence and advocacy.”
“However, he did not concede that any of his statements were misinformation, nor did the tribunal make such a determination,” noted lawyer Alan Honner.
While Hodkinson received a slap on the wrist, a number of Canadian doctors have faced much harsher sanctions for warning about the experimental vaccines or other COVID protocols such as lockdowns, including the revocation of their medical licenses, as was the case with Dr. Mark Trozzi and others.
Some of Hodkinson’s warnings seem to have been vindicated by the current Alberta government under Premier Danielle Smith, who commissioned Dr. Gary Davidson to investigate the previous administration’s handling of COVID-19.
Davidson’s report, which was made public earlier this year, recommended the immediately halt of the experimental jabs for healthy children and teenagers, citing the risks the shots pose.
Alberta
Province introducing “Patient-Focused Funding Model” to fund acute care in Alberta

Alberta’s government is introducing a new acute care funding model, increasing the accountability, efficiency and volume of high-quality surgical delivery.
Currently, the health care system is primarily funded by a single grant made to Alberta Health Services to deliver health care across the province. This grant has grown by $3.4 billion since 2018-19, and although Alberta performed about 20,000 more surgeries this past year than at that time, this is not good enough. Albertans deserve surgical wait times that don’t just marginally improve but meet the medically recommended wait times for every single patient.
With Acute Care Alberta now fully operational, Alberta’s government is implementing reforms to acute care funding through a patient-focused funding (PFF) model, also known as activity-based funding, which pays hospitals based on the services they provide.
“The current global budgeting model has no incentives to increase volume, no accountability and no cost predictability for taxpayers. By switching to an activity-based funding model, our health care system will have built-in incentives to increase volume with high quality, cost predictability for taxpayers and accountability for all providers. This approach will increase transparency, lower wait times and attract more surgeons – helping deliver better health care for all Albertans, when and where they need it.”
Activity-based funding is based on the number and type of patients treated and the complexity of their care, incentivizing efficiency and ensuring that funding is tied to the actual care provided to patients. This funding model improves transparency, ensuring care is delivered at the right time and place as multiple organizations begin providing health services across the province.
“Exploring innovative ways to allocate funding within our health care system will ensure that Albertans receive the care they need, when they need it most. I am excited to see how this new approach will enhance the delivery of health care in Alberta.”
Patient-focused, or activity-based, funding has been successfully implemented in Australia and many European nations, including Sweden and Norway, to address wait times and access to health care services, and is currently used in both British Columbia and Ontario in various ways.
“It is clear that we need a new approach to manage the costs of delivering health care while ensuring Albertans receive the care they expect and deserve. Patient-focused funding will bring greater accountability to how health care dollars are being spent while also providing an incentive for quality care.”
This transition is part of Acute Care Alberta’s mandate to oversee and arrange for the delivery of acute care services such as surgeries, a role that was historically performed by AHS. With Alberta’s government funding more surgeries than ever, setting a record with 304,595 surgeries completed in 2023-24 and with 310,000 surgeries expected to have been completed in 2024-25, it is crucial that funding models evolve to keep pace with the growing demand and complexity of services.
“With AHS transitioning to a hospital-based services provider, it’s time we are bold and begin to explore how to make our health care system more efficient and manage the cost of care on a per patient basis. The transition to a PFF model will align funding with patient care needs, based on actual service demand and patient needs, reflecting the communities they serve.”
“Covenant Health welcomes a patient-focused approach to acute care funding that drives efficiency, accountability and performance while delivering the highest quality of care and services for all Albertans. As a trusted acute care provider, this model better aligns funding with outcomes and supports our unwavering commitment to patients.”
“Patient-focused hospital financing ties funding to activity. Hospitals are paid for the services they deliver. Efficiency may improve and surgical wait times may decrease. Further, hospital managers may be more accountable towards hospital spending patterns. These features ensure that patients receive quality care of the highest value.”
Leadership at Alberta Health and Acute Care Alberta will review relevant research and the experience of other jurisdictions, engage stakeholders and define and customize patient-focused funding in the Alberta context. This working group will also identify and run a pilot to determine where and how this approach can best be applied and implemented this fiscal year.
Final recommendations will be provided to the minister of health later this year, with implementation of patient-focused funding for select procedures across the system in 2026.
-
Catherine Herridge2 days ago
FBI imposed Hunter Biden laptop ‘gag order’ after employee accidentally confirmed authenticity: report
-
Crime2 days ago
First Good Battlefield News From Trump’s Global War on Fentanyl
-
2025 Federal Election2 days ago
Don’t let the Liberals fool you on electric cars
-
2025 Federal Election2 days ago
Liberals Replace Candidate Embroiled in Election Interference Scandal with Board Member of School Flagged in Canada’s Election Interference Inquiry
-
Courageous Discourse1 day ago
Europe Had 127,350 Cases of Measles in 2024
-
2025 Federal Election2 days ago
Pierre Poilievre Declares War on Red Tape and Liberal Decay in Osoyoos
-
Podcasts19 hours ago
Trump’s Tariffs: The US, Canada, and the rest of the world
-
Alberta2 days ago
Is Canada’s Federation Fair?